Clinical trials
Terminated Small Cell Lung Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Pfizer | 4 |
| AbbVie | 3 |
| Bayer | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Incyte Corporation | 3 |
| Stanford University | 3 |
| Washington University School of Medicine | 3 |
| Case Comprehensive Cancer Center | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 110 |
| Carcinoma, Non-Small-Cell Lung | 35 |
| Lung Neoplasms | 28 |
| Melanoma | 16 |
| Carcinoma, Renal Cell | 11 |
| Neoplasm Metastasis | 11 |
| Squamous Cell Carcinoma of Head and Neck | 11 |
| Stomach Neoplasms | 11 |
| Carcinoma, Hepatocellular | 10 |
| Carcinoma, Merkel Cell | 10 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.